Liver fibrosis-4 score predicts mortality in critically ill patients with coronavirus disease 2019
Background: Emerging evidence suggests that liver dysfunction in the course of coronavirus disease 2019 (COVID-19) illness is a critical prognostic factor for mortality in COVID-19 patients, and the Fibrosis-4 (FIB-4) score, developed to reflect level of hepatic fibrosis, has been associated with ad...
Main Authors: | Mohammed Fawzi Abosamak, Ivan Szergyuk, Maria Helena Santos De Oliveira, Giuseppe Lippi, Ahmed Suliman Al-Jabbary, Amal H Al-Najjar, Marzooq A Albadi, Brandon M Henry |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | The Indian Anaesthetists' Forum |
Subjects: | |
Online Access: | http://www.theiaforum.org/article.asp?issn=2589-7934;year=2021;volume=22;issue=2;spage=149;epage=156;aulast=Abosamak |
Similar Items
-
Coronavirus disease 2019 vaccination‐induced acute exacerbation in idiopathic pulmonary fibrosis
by: Keishi Sugino, et al.
Published: (2022-11-01) -
Post–Coronavirus Disease 2019 Pulmonary Fibrosis: Wait or Needs Intervention
by: Hee-Young Yoon, et al.
Published: (2022-10-01) -
Nintedanib treatment for pulmonary fibrosis after coronavirus disease 2019
by: Hiroaki Ogata, et al.
Published: (2021-05-01) -
The second wave of desaturation in coronavirus disease 2019
by: M.I. Alghizzawi, et al.
Published: (2021-05-01) -
Molecular mechanisms and treatment responses of pulmonary fibrosis in severe COVID-19
by: Emma J. Kooistra, et al.
Published: (2023-08-01)